Itoh H - Search Results

1

Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice.

Miyamoto J, Watanabe K, Taira S, Kasubuchi M, Li X, Irie J, Itoh H, Kimura I. Miyamoto J, et al. Among authors: itoh h. PLoS One. 2018 Apr 26;13(4):e0196579. doi: 10.1371/journal.pone.0196579. eCollection 2018. PLoS One. 2018. PMID: 29698465 Free PMC article.

2

FOXP3/Scurfin gene polymorphism is associated with adult onset type 1 diabetes in Japanese, especially in women and slowly progressive-type patients.

Iwase K, Shimada A, Kawai T, Okubo Y, Kanazawa Y, Irie J, Oikawa Y, Hirose H, Maruyama T, Itoh H. Iwase K, et al. Among authors: itoh h. Autoimmunity. 2009 Feb;42(2):159-67. doi: 10.1080/08916930802488258. Autoimmunity. 2009. PMID: 19085184

3

Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label study.

Kawai T, Takei I, Shimada A, Hirata T, Tanaka K, Saisho Y, Irie J, Horimai C, Matsumoto H, Itoh H. Kawai T, et al. Among authors: itoh h. Clin Drug Investig. 2011;31(4):237-45. doi: 10.2165/11586510-000000000-00000. Clin Drug Investig. 2011. PMID: 21184621 Clinical Trial.

4

A mimic of viral double-stranded RNA triggers fulminant type 1 diabetes-like syndrome in regulatory T cell-deficient autoimmune diabetic mouse.

Tada A, Shimada A, Yamada T, Oikawa Y, Yamada Y, Okubo Y, Irie J, Bluestone JA, Itoh H. Tada A, et al. Among authors: itoh h. J Immunol. 2011 Nov 15;187(10):4947-53. doi: 10.4049/jimmunol.1000837. Epub 2011 Oct 3. J Immunol. 2011. PMID: 21967896

5

CCR2 knockout exacerbates cerulein-induced chronic pancreatitis with hyperglycemia via decreased GLP-1 receptor expression and insulin secretion.

Nakamura Y, Kanai T, Saeki K, Takabe M, Irie J, Miyoshi J, Mikami Y, Teratani T, Suzuki T, Miyata N, Hisamatsu T, Nakamoto N, Yamagishi Y, Higuchi H, Ebinuma H, Hozawa S, Saito H, Itoh H, Hibi T. Nakamura Y, et al. Among authors: itoh h. Am J Physiol Gastrointest Liver Physiol. 2013 Apr 15;304(8):G700-7. doi: 10.1152/ajpgi.00318.2012. Epub 2013 Feb 28. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 23449669 Free article.

6

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY).

Hirata T, Tomita K, Kawai T, Yokoyama H, Shimada A, Kikuchi M, Hirose H, Ebinuma H, Irie J, Ojiro K, Oikawa Y, Saito H, Itoh H, Hibi T. Hirata T, et al. Among authors: itoh h. Int J Endocrinol. 2013;2013:587140. doi: 10.1155/2013/587140. Epub 2013 Aug 13. Int J Endocrinol. 2013. PMID: 23997767 Free PMC article.

7

Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic Nephropathy.

Meguro S, Kabeya Y, Tanaka K, Kawai T, Tomita M, Katsuki T, Oikawa Y, Atsumi Y, Shimada A, Tanaka M, Irie J, Saisho Y, Itoh H. Meguro S, et al. Among authors: itoh h. Int J Endocrinol. 2013;2013:590569. doi: 10.1155/2013/590569. Epub 2013 Aug 26. Int J Endocrinol. 2013. PMID: 24065991 Free PMC article.

8

The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.

Sugizaki T, Watanabe M, Horai Y, Kaneko-Iwasaki N, Arita E, Miyazaki T, Morimoto K, Honda A, Irie J, Itoh H. Sugizaki T, et al. Among authors: itoh h. Endocrinology. 2014 Aug;155(8):2810-9. doi: 10.1210/en.2013-2143. Epub 2014 Apr 28. Endocrinology. 2014. PMID: 24773344

9

Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients.

Tanaka M, Nishimura R, Nishimura T, Kawai T, Meguro S, Irie J, Saisho Y, Itoh H. Tanaka M, et al. Among authors: itoh h. Diabetol Metab Syndr. 2014 May 18;6:56. doi: 10.1186/1758-5996-6-56. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 24860622 Free PMC article.

10

Relationships among different glycemic variability indices obtained by continuous glucose monitoring.

Saisho Y, Tanaka C, Tanaka K, Roberts R, Abe T, Tanaka M, Meguro S, Irie J, Kawai T, Itoh H. Saisho Y, et al. Among authors: itoh h. Prim Care Diabetes. 2015 Aug;9(4):290-6. doi: 10.1016/j.pcd.2014.10.001. Epub 2014 Nov 16. Prim Care Diabetes. 2015. PMID: 25456706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,927 results

Search Page